Bangma, C.
471  results:
Search for persons X
?
 
?
5

PIONEER: European Commission Innovative Medicines Initiativ..:

Evans Axelsson, S. ; Abbott, T. ; Fullwood, L....
European Urology Open Science.  19 (2020)  - p. e1798-e1799 , 2020
 
?
6

A first step towards a global nomogram to predict disease p..:

Van Hemelrijck, M. ; Ji, X. ; Helleman, J....
European Urology Open Science.  19 (2020)  - p. e1905-e1906 , 2020
 
?
7

Comparison of different biopsy schedules among men on activ..:

Beckmann, K. ; Bangma, C. ; Hellman, J....
European Urology Open Science.  19 (2020)  - p. e1561-e1562 , 2020
 
?
 
?
10

Can active surveillance really reduce the harms of overdiag..:

Drost, F.J. ; Bangma, C. ; Kakehi, Y....
European Urology Supplements.  17 (2018)  2 - p. e92-e95 , 2018
 
?
11

Large cribriform growth in Gleason 3+4=7 prostate cancer:

Hollemans, E. ; Verhoef, E. ; Bangma, C....
European Urology Supplements.  17 (2018)  14 - p. e2894 , 2018
 
?
12

Metastases and death after 15 year of follow-up in men with..:

Verbeek, J. ; Drost, F.-J. ; Bangma, C..
European Urology Supplements.  16 (2017)  3 - p. e1400-e1401 , 2017
 
?
13

Adherence to active surveillance protocols for low-risk pro..:

Roobol, M.J. ; Verbeek, J. ; Nieboer, D....
European Urology Supplements.  16 (2017)  10 - p. e2632-e2635 , 2017
 
?
14

The prevalence and progression of lower urinary tract sympt..:

Venderbos, L. ; Bangma, C. ; Roobol, M.
European Urology Supplements.  16 (2017)  3 - p. e689-e690 , 2017
 
?
15

Value of magnetic resonance imaging in population-based pro..:

Alberts, A. ; Schoots, I. ; Drost, F.-J....
European Urology Supplements.  16 (2017)  3 - p. e867-e868 , 2017
 
1-15